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INTRODUCTION
Patients with a long-standing history of seizures are
more susceptible to develop major psychiatric disorders
including chronic interictal psychosis and episodic
psychotic states (1,2). The different psychotic
syndromes associated with epilepsy are normally
defined based on their chronological relation to the
seizures. Interictal psychosis occurs without an
antecedent seizure, or an increase in seizure activity (1),
and results in persistent psychotic states of varying
intervals (3). Postictal psychosis, on the other hand, is
an episodic psychotic state that classically follows
exacerbations of seizures, particularly clusters of
complex partial seizures with or without generalization
(4). A lucid period of 12 hours to 6 days after
termination of seizure activity precedes the onset of
psychiatric symptoms, which often remit spontaneously
within days or weeks (5). Patients frequently present
with auditory, olfactory, gustatory and/or visceral
hallucinations, paranoid ideation, and cognitive
dysfunction.
CASE REPORT
Ms. T. is a 31-year-old female who presented in a
confused, but alert state after having experienced 3
episodes of seizure activity in 6 days. Upon
interviewing she reported that she did not feel like her
usual self and feared that something was wrong with her
brain. Following her second seizure, she began having
visceral hallucinations in her abdomen and groin.
Within 24 hours of her third seizure, she had begun to
hear voices emerging from her abdomen. The
synchronicity of these two symptoms produced a deep
anxiety that she was becoming homosexual. The patient
also expressed a feeling of responsibility for the
suffering of innocent people and as a result, believed
that she was being watched. Upon declaration of
suicidal intentions, she was started on low dose
haloperidol. Her psychoses resolved following two
weeks of low dose haloperidol and strict administration
of carbamazepine and lamotrigine.
Given our patient’s previous hospital admissions for
episodes of acute psychosis following a period of
poorly controlled seizures, she has an increased risk for
developing chronic psychosis from her repeated
episodes of postictal psychoses (6,7). While there exists
no published trials on the prevention of chronic
psychosis, or the symptomatic or prophylactic treatment
of postictal psychosis, treatment recommendations
based on expert opinion have appeared in the literature
in the field of neurology, which were followed for this
patient. She was discharged on 200 mg carbamazepine
BID, 75 mg lamotrigine BID and 0.5 mg risperidone
BID. Follow-up as an outpatient was required in order
to monitor her anticonvulsant levels, and to titrate the
risperidone up to 1 mg BID, which was discontinued
once she had achieved a prolonged period free of
seizure activity and psychosis.
DISCUSSION
Epilepsy on average affects up to 1.5% of the general
population, of which 0.8% has been admitted to hospital
for schizophrenia and 1.5% for schizophrenia-like
psychosis (8). Compared to the general population
where the risk of developing schizophrenia is 1%,
patients with a history of seizures have an increased risk
of 2.5% (6). This risk further increases with the number
of hospital admissions for epilepsy (6).Alatency period
of 8 to 15 years was noted between the onset of epilepsy
and the patient’s first hospital admission for psychiatric
issues (5,7). Numerous epidemiological risk factors
have been identified, including female sex, early onset
epilepsy, long-standing epilepsy, intractable epilepsy,
secondary generalization of seizures, and left and/or
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bilateral foci (1).
The propensity to develop postictal psychosis may
have some link to the proximity of the seizure focus to
limbic structures (8). While the neuropathology of
epileptic psychoses remains undetermined, it is believed
to be related to abnormal electrical discharges
frequently localized to the temporal-frontal lobe and
cerebellum (4,7), but can also occur with widespread
electrical activity (1). It has been proposed that these
epileptiform disturbances result in aberrant regeneration
and wiring of neurons, cortical dysgenesis, diffuse brain
damage and developmental lesions affecting the
connectivity of limbic structures (1).
The patient has a history of seizures in early
childhood following a cerebral infarct, compounded by
a 10-year history of poorly controlled adult epilepsy.An
MRI scan performed 3 years earlier confirmed a pre-
existing right middle cerebral artery infarction with
sparing of the basal ganglia. During her current
admission she underwent computed tomography (CT)
and an electroencephalogram (EEG). The CT revealed
significant atrophy of the right temporal lobe, but no
new lesions or recent infarcts. The EEG confirmed that
she was having complex partial seizures with temporal
lobe focus and secondary generalization.
While postictal psychosis has been well described in
adults, the lack of ICD-10 or DSM-IV classification and
the lack of treatment recommendations make the use of
prophylactic neuroleptics experimental and
problematic. When choosing an antipsychotic
medication, it is important to consider the potential
additive effect that occurs with the antiepileptic
medication. This can increase the number of side effects
and toxic effects experienced by the patient, in addition
to the pharmacokinetic interactions that can occur
during the absorption, distribution, excretion, and
biotransformation, resulting in a reduced epileptogenic
threshold (ET) and an increase in seizure activity (3).
The extent of these adverse effects will vary based on
the specific medication, the dosage and duration of use
(3). Nevertheless, these numerous unfavorable effects
often lead to a high level of non-compliance among
patients.
Typical neuroleptics with a low potency such as
phenothiazine have been observed to decrease the ET
(3). Conversely, highly potent typical neuroleptics like
haloperidol demonstrate antipsychotic action at low
dose with little effect on the ET, making it one of the
safest antipsychotics used to treat postictal psychosis
(3). However, haloperidol has a higher risk of
extrapyramidal symptoms (EPS), and therefore its use
as a first-line treatment for our patient’s postictal
psychosis was reserved solely for resolving active
psychoses. She was then switched to risperidone, an
atypical neuroleptic with less EPS side effects, minimal
effects on the serum concentration of prolactin, and a
positive effect on the negative and dysphoric symptoms
of epilepsy that may accompany the psychosis of
epilepsy (3).
Both haloperidol and risperidone are weak inhibitors
of the hepatic microsomal P450 cytochrome oxidase
system (CYP), limiting their effect on the metabolism
of concomitantly administered antiepileptic drugs (3).
On the other hand, carbamazepine can reduce the
plasma concentration of haloperidol and risperidone via
induction of CYP3A4, thus compromising the efficacy
of psychiatric treatment (3). Lamotrigine, however, is
metabolized predominantly by glucuronic acid
conjugation with no affect on the cytochrome oxidase
system, making it a relatively safe adjunct therapy.
The evaluation and treatment of epileptic patients
who present with psychiatric manifestations prove to be
complex issues. Although postictal psychoses is
relatively rare, this case highlights the importance of
seizure control in patients with long-standing epilepsy
and the need for prophylactic and treatment protocols
for patients at risk of developing epileptic psychoses.
Figure 1a. CT scan, axial section of the brain showing a right middle
cerebral artery infacrt limited to the right temporal lobe.
Figure 1b. CT scan, axial section of the brain showing a right middle
cerebral artery infacrt limited to the right temporal lobe.24 McGill Journal of Medicine 2008
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